Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies

BACKGROUND: Early antifungal therapy for invasive aspergillosis (IA) has been associated with improved outcome. Traditionally, of empiric antifungal therapy has been used for clinically suspected IA. We compared outcomes of patients with hematologic malignancy and IA who were treated with voriconazo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dib, Rita Wilson, Hachem, Ray Y., Chaftari, Anne-Marie, Ghaly, Fady, Jiang, Ying, Raad, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293532/
https://www.ncbi.nlm.nih.gov/pubmed/30545320
http://dx.doi.org/10.1186/s12879-018-3584-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293532/
https://www.ncbi.nlm.nih.gov/pubmed/30545320
http://dx.doi.org/10.1186/s12879-018-3584-9

Ejemplares similares